Frederick G. Vogt
Interim CEO & General Counsel at Iovance Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Iovance Biotherapeutics Inc., 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +15,626 | — | — |
| Sep 8, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −6,638 | $8.70 | $57,751 |
| Sep 1, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +41,669 | — | — |
| Sep 1, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −17,702 | $8.28 | $146,573 |
| Jun 5, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +15,625 | — | — |
| Jun 5, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −6,638 | $4.23 | $28,079 |
| Jun 1, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +41,668 | — | — |
| Jun 1, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −17,701 | $3.96 | $70,096 |
| Mar 5, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +62,493 | — | — |
| Mar 5, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −26,755 | $4.58 | $122,538 |
| Mar 2, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +52,087 | — | — |
| Mar 2, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −22,809 | $3.79 | $86,446 |
| Dec 2, 2025 | Iovance Biotherapeutics Inc. | Option exercise | +10,417 | — | — |
| Dec 2, 2025 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −4,426 | $2.14 | $9,472 |
| Dec 1, 2025 | Iovance Biotherapeutics Inc. | Option exercise | +41,669 | — | — |
Questions about Frederick G. Vogt
What boards is Frederick G. Vogt on?
Frederick G. Vogt sits on the board of Iovance Biotherapeutics Inc.
What company is Frederick G. Vogt the CEO of?
Frederick G. Vogt is Interim CEO & General Counsel of Iovance Biotherapeutics Inc.
How long has Frederick G. Vogt served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.